Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steffie M B Peters

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 3, 2025
Current Developments in Combining External-Beam Radiotherapy and <sup>177</sup>Lu-Labeled PSMA Ligands for Prostate Cancer TreatmentFrederik R Teunissen, Daniela E Oprea-Lager, Steffie M B Peters, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 8, 2023
Urinary excretion kinetics of [<sup>177</sup>Lu]Lu-PSMA-617Maarten de Bakker, Noa Dominicus, Antoi Meeuwis, et al.
EJNMMI Physics|April 3, 2024
Bone marrow dosimetry in low volume mHSPC patients receiving Lu-177-PSMA therapy using SPECT/CTDagmar Grob, Bastiaan M Privé, Constantijn H J Muselaers, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|December 6, 2024
Single-time-point dosimetry using model selection and the Bayesian fitting method: A proof of conceptBisma B Patrianesha, Steffie M B Peters, Deni Hardiansyah, et al.
EJNMMI Physics|June 4, 2020
A head-to-head comparison between two commercial software packages for hybrid dosimetry after peptide receptor radionuclide therapyDaphne M V Huizing, Steffie M B Peters, Michelle W J Versleijen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 14, 2022
Thoughts on "Tumor Sink Effect in <sup>68</sup>Ga-PSMA-11 PET: Myth or Reality?"Bastiaan M Privé, Steffie M B Peters, Maike J M Uijen, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 10, 2023
Population pharmacokinetic dosimetry model using imaging data to assess variability in pharmacokinetics of <sup>177</sup> Lu-PSMA-617 in prostate cancer patientsHinke Siebinga, Bastiaan M Privé, Steffie M B Peters, et al.
Zeitschrift Fur Medizinische Physik|July 3, 2026
Limitations of Mono-Exponential Individual Fitting as a Reference Model for Single-Time-Point Dosimetry in [<sup>177</sup>Lu]Lu-PSMA-617 TherapyFulki Fiarka, Assyifa Rahman Hakim, Indra Budiansah, et al.
Nuclear Medicine Communications|January 4, 2023
Kidney absorbed radiation doses for [ 177 Lu]Lu-PSMA-617 and [ 177 Lu]Lu-PSMA-I&T determined by 3D clinical dosimetryMaike J M Uijen, Bastiaan M Privé, Carla M L van Herpen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 22, 2023
Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre)clinical studiesBastiaan M Privé, Mohamed A Boussihmad, Bart Timmermans, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 3, 2025
Current Developments in Combining External-Beam Radiotherapy and <sup>177</sup>Lu-Labeled PSMA Ligands for Prostate Cancer TreatmentFrederik R Teunissen, Daniela E Oprea-Lager, Steffie M B Peters, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 8, 2023
Urinary excretion kinetics of [<sup>177</sup>Lu]Lu-PSMA-617Maarten de Bakker, Noa Dominicus, Antoi Meeuwis, et al.
EJNMMI Physics|April 3, 2024
Bone marrow dosimetry in low volume mHSPC patients receiving Lu-177-PSMA therapy using SPECT/CTDagmar Grob, Bastiaan M Privé, Constantijn H J Muselaers, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|December 6, 2024
Single-time-point dosimetry using model selection and the Bayesian fitting method: A proof of conceptBisma B Patrianesha, Steffie M B Peters, Deni Hardiansyah, et al.
EJNMMI Physics|June 4, 2020
A head-to-head comparison between two commercial software packages for hybrid dosimetry after peptide receptor radionuclide therapyDaphne M V Huizing, Steffie M B Peters, Michelle W J Versleijen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 14, 2022
Thoughts on "Tumor Sink Effect in <sup>68</sup>Ga-PSMA-11 PET: Myth or Reality?"Bastiaan M Privé, Steffie M B Peters, Maike J M Uijen, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 10, 2023
Population pharmacokinetic dosimetry model using imaging data to assess variability in pharmacokinetics of <sup>177</sup> Lu-PSMA-617 in prostate cancer patientsHinke Siebinga, Bastiaan M Privé, Steffie M B Peters, et al.
Zeitschrift Fur Medizinische Physik|July 3, 2026
Limitations of Mono-Exponential Individual Fitting as a Reference Model for Single-Time-Point Dosimetry in [<sup>177</sup>Lu]Lu-PSMA-617 TherapyFulki Fiarka, Assyifa Rahman Hakim, Indra Budiansah, et al.
Nuclear Medicine Communications|January 4, 2023
Kidney absorbed radiation doses for [ 177 Lu]Lu-PSMA-617 and [ 177 Lu]Lu-PSMA-I&T determined by 3D clinical dosimetryMaike J M Uijen, Bastiaan M Privé, Carla M L van Herpen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 22, 2023
Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre)clinical studiesBastiaan M Privé, Mohamed A Boussihmad, Bart Timmermans, et al.
Pageof 3